RTP Mobile Logo

Saturday, October 28, 2017, Orlando, FL | 8:00 AM – 4:00 PM (Eastern Time)

Year in Review — A Multitumor Regional Symposia Series Focused on the Application of Emerging Research Information to the Care of Patients with Common Cancers

 

Event Details

Date:
Saturday, October 28, 2017

Program Time:
8:00 AM – 4:00 PM (Eastern Time)
Breakfast and lunch to be provided

Location:
JW Marriott Orlando Grande Lakes
4040 Central Florida Parkway
Orlando, FL 32837
Hotel Phone: (407) 206-2300

Meeting Room:
Mediterranean Ballroom 1-4 (Lobby Level)

Hotel Accommodations:
A special rate of $195 (Standard Deluxe Room) has been arranged for the meeting. Please see the Location tab for additional details.

 
There is no registration fee for this event. Preregistration is advised as seating is limited.


Faculty:
Acute Leukemia

Harry P Erba, MD, PhD
Albert F LoBuglio Endowed Chair for Translational Cancer Research
Chair, SWOG Leukemia Committee
Professor, Internal Medicine
Director, Hematologic Malignancy Program
University of Alabama at Birmingham
Birmingham, Alabama

Hagop M Kantarjian, MD
Chairman and Professor, Leukemia Department
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Breast Cancer

Joyce O’Shaughnessy, MD
Chair, Breast Cancer Research Program
Baylor Charles A Sammons Cancer Center
Celebrating Women Chair in Breast Cancer Research
Texas Oncology
US Oncology
Dallas, Texas

Hope S Rugo, MD
Professor of Medicine
Director, Breast Oncology and Clinical Trials Education
University of California, San Francisco
Helen Diller Family Comprehensive Cancer Center
San Francisco, California

Gastrointestinal Cancer

Axel Grothey, MD
Professor of Oncology
Department of Medical Oncology
Mayo Clinic
Rochester, Minnesota

Additional faculty to be announced

Genitourinary Cancer

William K Oh, MD
Chief, Division of Hematology and Medical Oncology
Professor of Medicine and Urology
Ezra M Greenspan, MD Professor in Clinical Cancer Therapeutics
Icahn School of Medicine at Mount Sinai
Associate Director of Clinical Research
The Tisch Cancer Institute
Mount Sinai Health System
New York, New York

Daniel P Petrylak, MD
Professor of Medicine
Director, Prostate and GU Medical Oncology
Co-Director, Signal Transduction Program
Yale Cancer Center
New Haven, Connecticut

Lung Cancer

Gregory J Riely, MD, PhD
Associate Attending
Memorial Sloan Kettering Cancer Center
New York, New York

Heather Wakelee, MD
Associate Professor of Medicine
Division of Oncology
Stanford University School of Medicine
Stanford Cancer Institute
Stanford, California

Additional faculty to be announced

Lymphoma

Jeremy Abramson, MD
Director of the Lymphoma Program
Jon and Jo Ann Hagler Chair in Lymphoma
Massachusetts General Hospital Cancer Center
Assistant Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Ann S LaCasce, MD, MMSc
Program Director, Fellowship in Hematology/Oncology
Associate Professor of Medicine, Harvard Medical School
Lymphoma Program
Dana-Farber Cancer Institute
Boston, Massachusetts

Sonali M Smith, MD
Associate Professor
Section of Hematology/Oncology
Director, Lymphoma Program
The University of Chicago
Chicago, Illinois

Ovarian Cancer

Michael Birrer, MD, PhD
Director, UAB Comprehensive Cancer Center
University of Alabama at Birmingham
Birmingham, Alabama

Additional faculty to be announced

Moderator:
Neil Love, MD
Research To Practice
Miami, Florida

 

Agenda

We are pleased to be able once again to host this multitumor educational program titled Year in Review. For this daylong event we have recruited an exceptional faculty panel that will review many of the year’s most important new data sets and conference presentations in several distinct areas of oncology: breast cancer, lung cancer, ovarian cancer, genitourinary cancers, select gastrointestinal cancers, Hodgkin and non-Hodgkin lymphoma and acute leukemias.

Full agenda to be announced in the late summer.

CE Information

Target Audience:
This live activity has been designed to meet the educational needs of medical oncologists, hematologists, hematology-oncology fellows, nurse practitioners, clinical nurse specialists and other allied cancer professionals.

Learning Objectives and Goals:
At the conclusion of this activity, participants should be able to:

  • Effectively apply the results of practice-changing clinical research to the care of patients with breast, lung, gastrointestinal, genitourinary, ovarian and select hematologic cancers.
  • Appraise the clinical relevance of recent pivotal cancer research results published in peer-reviewed journals and/or presented at major oncology conferences.
  • Recall ongoing trials in breast, lung, gastrointestinal, genitourinary, ovarian and select hematologic cancers, and refer appropriate patients for study participation.
  • Use an understanding of tumor biomarkers and single and multigene signatures to individualize the care of patients with cancer.
  • Educate patients with diverse hematologic cancers and solid tumors about the benefits and risks of new therapeutic agents and strategies.
  • Refine or validate existing cancer-specific treatment algorithms based on exposure to new data sets and the perspectives of tumor-specific clinical investigators.
  • Recognize immune-related adverse events and other common side effects associated with approved and developmental immunotherapeutic drugs in order to offer supportive management strategies.
  • Evaluate the mechanisms of action, tolerability and efficacy of promising investigational agents, and consider their potential implications for clinical practice.

Accreditation Statements:
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Research To Practice is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

CME Credit Designation Statement:
Research To Practice designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit Designation Statements:
This educational activity for 6.75 contact hours is provided by Research To Practice.

This activity is awarded 6.75 ANCC pharmacotherapeutic contact hours.

ONCC/ILNA Certification Information:
This program will be submitted for ONCC/ILNA certification.

CME Credit Form:
A credit form will be given to each participant at the conclusion of the activity.

CNE Credit Form:
To obtain a certificate of completion and receive credit for this event, nurses must sign in at the registration desk upon arrival, attend the entire activity and return a completed Educational Assessment and Credit Form upon exiting the activity.

Disclosure Policy:
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess conflicts of interest with faculty, planners and managers of CME/CNE activities. Conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. Financial disclosures will be provided in meeting course materials.

Educational Support:
This activity is supported by educational grants from Agios Pharmaceuticals Inc, Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals Inc, Boston Biomedical Pharma Inc, Bristol-Myers Squibb Company, Celgene Corporation, Clovis Oncology, Eisai Inc, Exelixis Inc, Genentech BioOncology, Genomic Health Inc, Gilead Sciences Inc, ImmunoGen Inc, Ipsen Biopharmaceuticals Inc, Lexicon Pharmaceuticals Inc, Lilly, Novartis, Sanofi Genzyme, Seattle Genetics, Taiho Oncology Inc, Takeda Oncology and Tesaro Inc.

Unlabeled/Unapproved Uses Notice:
There is no implied or real endorsement of any product by Research To Practice, the Accreditation Council for Continuing Medical Education or American Nurses Credentialing Center. Any off-label use as declared by the FDA will be identified.

Research To Practice staff and external reviewers — The scientific staff and reviewers for Research To Practice have no relevant conflicts of interest to disclose.

Location

JW Marriott Orlando Grande Lakes
4040 Central Florida Parkway
Orlando, FL 32837
Hotel Phone: (407) 206-2300

Meeting Room: Mediterranean Ballroom 1-4 (Lobby Level)

Room Reservations:
A special rate of $195 (Standard Deluxe Room) has been arranged for meeting attendees. Please contact the JW Marriott Orlando Grande Lakes hotel for reservations at (800) 266-9432. A personal credit card will be required to secure accommodations.

Be sure to mention the following reference code when calling the hotel to receive the group rate: Year in Review 2017.

Florida Cancer Specialists (FCS) members, please be sure to book accommodations in the FCS room block.

Room reservations must be made by Thursday, October 5, 2017. A limited number of rooms are available, and we encourage you to make your reservations early.

Registration

This live activity has been designed to meet the educational needs of medical oncologists, hematologists, hematology-oncology fellows, nurse practitioners, clinical nurse specialists and other allied cancer professionals.

At this time registration for this educational activity is open to clinicians in practice only. If you are a clinician, please continue below to register for this event. There is no registration fee for this event. Preregistration is advised as seating is limited.

For all other professionals,* we are unable to confirm seating at this time. If you would like to stand by for participation in this event, please provide your contact information after clicking the second registration option below. Should seats become available for the program, we will notify you.

Registration for clinicians in practice

I am a practicing physician, nurse, fellow or other healthcare provider involved in the treatment of cancer.

Registration for clinicians in practice »
 
STANDBY registration for other/industry professionals*

STANDBY registration for other/industry professionals.*

Standby registration for industry professionals »

* Individuals employed by for-profit organizations, including financial institutions, biotech or pharmaceutical companies
Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating, please check in at our onsite registration desk at least 30 minutes prior to the start of the meeting. We cannot guarantee seating after the start of the program.

Meal service will be provided to those who attend the program, based on availability.

Photography and/or video recording may be taken during the educational program by Research To Practice and used in future CME/CNE programs.

Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153.